Anavex Life Sciences Corp (AVXL)

[Reyeton]

Checkered track record would certainly describe a CEO that is focused on bringing a product to market. Right on track would certainly describe a CEO that is getting all the ducks lined up and then not moving forward but stalling, waiting for a take-over bid. We are a small company with a massive portfolio. Small companies like us lack the wherewithal to bring a product to market unless they farm out the manufacturing, packaging and distribution, accepting the risk to quality control. Big Pharma has massive cash reserves but also have some of their big moneymakers coming off patent. Timing is everything. If Missling’s plan is the above, his timing seems to be coming online.